Cargando…

Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections

Pulmonary mold infections are life-threatening diseases with high morbi-mortalities. Treatment is based on systemic antifungal agents belonging to the families of polyenes (amphotericin B) and triazoles. Despite this treatment, mortality remains high and the doses of systemic antifungals cannot be i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brunet, Kévin, Martellosio, Jean-Philippe, Tewes, Frédéric, Marchand, Sandrine, Rammaert, Blandine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949245/ https://www.ncbi.nlm.nih.gov/pubmed/35336015 http://dx.doi.org/10.3390/pharmaceutics14030641

Ejemplares similares

Improved In Vitro Anti-Mucorales Activity and Cytotoxicity of Amphotericin B with a Pegylated Surfactant
por: Brunet, Kévin, et al.
Publicado: (2022)

Late Onset of Chronic Granulomatous Disease Revealed by Paecilomyces lilacinus Cutaneous Infection
por: Lemaigre, Clément, et al.
Publicado: (2021)

What Could Be the Role of Antifungal Lock-Solutions? From Bench to Bedside
por: Imbert, Christine, et al.
Publicado: (2018)

PK-PD Evaluation of Inhaled Microparticles loaded with Ciprofloxacin-Copper complex in a Rat Model of Chronic Pseudomonas aeruginosa Lung Infection.
por: Tewes, Frederic, et al.
Publicado: (2023)

Invasive Candida bovina Infection, France
por: Brunet, Kévin, et al.
Publicado: (2020)

Mold-Active Antifungal Prophylaxis in Pediatric Patients with Cancer or Undergoing Hematopoietic Cell Transplantation
por: Lehrnbecher, Thomas, et al.
Publicado: (2023)

Invasive Mold Infections (IMI) among Liver Transplant Recipients (LTR): Is It Time to Reconsider the Risk Factors that Determine Antifungal Prophylaxis?
por: Neyra, Karyna, et al.
Publicado: (2017)

Antifungal Prophylaxis
por: Johnson, Douglas Clark, et al.
Publicado: (2021)

Utilization of Inhaled Corticosteroids for Infants with Bronchopulmonary Dysplasia
por: Slaughter, Jonathan L., et al.
Publicado: (2014)

Inhaled Bronchodilator Use for Infants with Bronchopulmonary Dysplasia
por: Slaughter, Jonathan L, et al.
Publicado: (2014)

Management of invasive aspergillosis in patients with COPD: Rational use of voriconazole
por: Ader, Florence, et al.
Publicado: (2009)

Reply: Antifungal Prophylaxis
por: Pennington, Kelly M., et al.
Publicado: (2021)

Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination
por: Rojas, Rafael, et al.
Publicado: (2012)

Closing the Gap in Surveillance and Audit of Invasive Mold Diseases for Antifungal Stewardship Using Machine Learning
por: Baggio, Diva, et al.
Publicado: (2019)

Network meta-analysis of triazole, polyene, and echinocandin antifungal agents in invasive fungal infection prophylaxis in patients with hematological malignancies
por: Zeng, Huilan, et al.
Publicado: (2021)

Inhaled bronchodilator exposure in the management of bronchopulmonary dysplasia in hospitalized infants
por: Euteneuer, Joshua C., et al.
Publicado: (2020)

A Spreading Concern: Inhalational Health Effects of Mold
por: Weinhold, Bob
Publicado: (2007)

Antifungal Prophylaxis in Immunocompromised Patients
por: Vazquez, Lourdes
Publicado: (2016)

2252. Patient Preferences for Triazole Antifungals in the Treatment of Invasive Mold Infection: A Discrete Choice Experiment
por: Bhagat, Hardik, et al.
Publicado: (2019)

PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections
por: Murray, Alison, et al.
Publicado: (2020)

Clinical Uses of Inhaled Antifungals for Invasive Pulmonary Fungal Disease: Promises and Challenges
por: Vuong, Nancy N., et al.
Publicado: (2023)

Use of Inhaled Iloprost in an Infant With Bronchopulmonary Dysplasia and Pulmonary Artery Hypertension
por: Hwang, Seung-Kyung, et al.
Publicado: (2009)

Potential Applications and Antifungal Activities of Engineered Nanomaterials against Gray Mold Disease Agent Botrytis cinerea on Rose Petals
por: Hao, Yi, et al.
Publicado: (2017)

Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation
por: Glampedakis, Emmanouil, et al.
Publicado: (2021)

Antifungal prophylaxis in critically ill patients
por: Silvestri, Luciano, et al.
Publicado: (2008)

Editorial Commentary: Galactomannan Testing During Mold-Active Prophylaxis
por: Cornely, Oliver A.
Publicado: (2014)

Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent
por: Cass, Lindsey, et al.
Publicado: (2020)

Modulation of pulmonary desmosomes by inhaler therapy in preterm-born children with bronchopulmonary dysplasia
por: Course, Christopher W., et al.
Publicado: (2023)

PRO: Biomarker surveillance for invasive fungal infections without antifungal prophylaxis could safely reduce antifungal use in acute leukaemia
por: Taynton, Thomas, et al.
Publicado: (2022)

Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections
por: Angulo, David A., et al.
Publicado: (2022)

Melioidosis Requires Better Data Sharing for Improved Diagnosis and Management in the Mekong Region
por: Rammaert, Blandine, et al.
Publicado: (2014)

Fluconazole is as effective as other anti-mold agents in preventing early invasive fungal disease after allogeneic stem cell transplantation: assessment of antifungal therapy in haematological disease in China
por: Sun, Yuqian, et al.
Publicado: (2020)

Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta‐analysis
por: Gatti, Milo, et al.
Publicado: (2021)

755. Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies
por: Almutairy, Reem F, et al.
Publicado: (2020)

Epidemiology and Risk Factors for Invasive Fungal Infections in Pancreas Transplant in the Absence of Postoperative Antifungal Prophylaxis
por: Zachary, Jessica, et al.
Publicado: (2023)

Inhaled nitric oxide in premature infants for preventing bronchopulmonary dysplasia: a meta-analysis
por: Zheng, Yi, et al.
Publicado: (2023)

Lipid Nanoparticles Loaded with Farnesol or Geraniol to Enhance the Susceptibility of E. coli MCR-1 to Colistin
por: Valcourt, Chantal, et al.
Publicado: (2021)

Molecular characterization and antifungal activity against non-dermatophyte molds causing onychomycosis
por: Pakshir, Keyvan, et al.
Publicado: (2021)

Limited Index of Clinical Suspicion and Underdiagnosis of Histopathologically Documented Invasive Mold Infections
por: Caudron de Coquereaumont, Grégoire, et al.
Publicado: (2021)

Investigational Agents for the Treatment of Resistant Yeasts and Molds
por: Seiler, Garret T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c9bankn043delu8od1838p8f7e